Condition
HR+/HER2-negative Breast Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 HR+/HER2-negative Breast Cancer clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Spain (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Evaluating TOS-358 for safety in adults with certain solid tumors
This study is testing a new medication called TOS-358 to see if it's safe for adults with certain types of solid tumors, like specific breast and head and neck cancers.
-
Combination treatment for advanced breast cancer with specific genetic alterations
This study is testing a new combination of three drugs to see if it can help people with advanced breast cancer that has certain genetic changes while keeping track of any side effects like high blood sugar.
Related topics
Quick answers
How many HR+/HER2-negative Breast Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.